Drug Profile
Mirostipen
Alternative Names: HG 00300; HGO 0300; MPIF 1; Myeloid progenitor inhibitory factor 1Latest Information Update: 17 Apr 2002
Price :
$50
*
At a glance
- Originator Human Genome Sciences
- Class Antineoplastics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Myelosuppression